# Avacostar - (PASS)

> **NCT05897684** · — · RECRUITING · sponsor: **Vifor Fresenius Medical Care Renal Pharma** · enrollment: 500 (estimated)

## Conditions studied

- ANCA-associated Vasculitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05897684
- **Lead sponsor:** Vifor Fresenius Medical Care Renal Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-11
- **Primary completion:** 2030-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05897684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05897684, "Avacostar - (PASS)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05897684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*